NCT03543800 is a NA clinical trial of Cytorich PRP kit in Osteoarthritis of the Knee, sponsored by Antnor.

Who is sponsoring NCT03543800?

NCT03543800 is sponsored by Antnor.

What drugs are being tested in NCT03543800?

Interventions in NCT03543800: Cytorich PRP kit, PRP kit.

What condition does NCT03543800 study?

NCT03543800 studies Osteoarthritis of the Knee.

Is NCT03543800 still recruiting?

NCT03543800 is currently status unknown. Last updated 1 June 2018.

Last reviewed 2018-06-01 · How we verify

NCT03543800

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PRP Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)

Status unknown NA Last updated 1 June 2018

What this trial tests

NA trial testing Cytorich PRP kit in Osteoarthritis of the Knee in 100 participants. Status unknown.

Timeline

4 February 2015

Primary endpoint
20 May 2019

20 May 2019

Quick facts

Lead sponsor	Antnor
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	4 February 2015
Primary completion	20 May 2019
Estimated completion	20 May 2019
Sites	1 location across Canada

Drugs / interventions tested

Cytorich PRP kit
PRP kit

Conditions studied

Osteoarthritis of the Knee — all drugs for Osteoarthritis of the Knee →

Sponsor

Antnor

Who can join

Adults 18 to 80, any sex, with Osteoarthritis of the Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed at evaluating the efficacy and safety of Cytorich compared to platelet-rich plasma (PRP) in alleviating pain and improving function in subjects with knee OA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis of the Knee

Currently open trials in the same condition.

NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
NCT06549686 — A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee · Phase 3 · recruiting
NCT05985785 — Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection · NA · recruiting
NCT05035810 — A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in · Phase 3 · active not recruiting
NCT04992624 — Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Antnor
Last refreshed: 1 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing